{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T07:16:13Z","timestamp":1698822973077},"reference-count":5,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T00:00:00Z","timestamp":1311465600000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Dapsone is regarded as the treatment of choice for linear immunoglobulin A disease (chronic bullous disease of childhood). It is associated with both hemolytic anemia and methemoglobinemia. The hematotoxic effects are dose related and can result in significant hemolysis. We present a case of a patient with chronic bullous disease of childhood and alpha thalassemia trait. Complete resolution occurred on a standard dose of dapsone without significant hemolysis.<\/jats:p>","DOI":"10.1111\/j.1525-1470.2011.01307.x","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T13:11:45Z","timestamp":1311685905000},"page":"471-473","source":"Crossref","is-referenced-by-count":1,"title":["Linear IgA Disease: Complicated by Alpha Thalassemia"],"prefix":"10.1111","volume":"28","author":[{"given":"MELISSA","family":"SCORZA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENNETH","family":"GALECKAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,7,24]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1997.tb00954.x"},{"key":"e_1_2_3_3_2","first-page":"359","volume-title":"Hurwitz: clinical pediatric dermatology","author":"Paller AS","year":"2006"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30247-X"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546630801958246"},{"key":"e_1_2_3_6_2","first-page":"230","volume-title":"Comprehensive dermatologic drug therapy","author":"Hall RP","year":"2001"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2011.01307.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2011.01307.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:47:37Z","timestamp":1698756457000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2011.01307.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1111\/j.1525-1470.2011.01307.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01307.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}